Furthermore, Kaplan‐Meier analysis of the data obtained from Taylor and TCGA databases indicated that patients with PCa who express low levels of CES1 (above the 50th percentile) had shorter BRFS (p = 0.0068) and DFS (p = 0.0282) than patients with PCa who express high levels of CES1 (below the 50th percentile) (Figures 3D and S3C). This evidence concerns the gene CES1 and posterior cortical atrophy.